MCM
TEVA icon

MAI Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

MAI Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$302K Buy
8,901
+5,377
+153% +$179K ﹤0.01% 1585
2026
Q1 		$106K Sell
3,524
-631
-15% -$20.3K ﹤0.01% 1802
2025
Q4 		$130K Sell
4,155
-426
-9% -$10.5K ﹤0.01% 1506
2025
Q3 		$92.5K Buy
4,581
+1,288
+39% +$22.6K ﹤0.01% 1615
2025
Q2 		$55.2K Buy
3,293
+697
+27% +$11.2K ﹤0.01% 1799
2025
Q1 		$39.9K Sell
2,596
-50
-2% -$893 ﹤0.01% 1857
2024
Q4 		$58.3K Buy
+2,646
New +$48.1K ﹤0.01% 1686
2018
Q3 		– Sell
-8,392
Closed -$204K – 501
2018
Q2 		$204K Buy
+8,392
New +$171K 0.01% 447
2017
Q3 		– Sell
-17,904
Closed -$595K – 461
2017
Q2 		$595K Sell
17,904
-6,024
-25% -$186K 0.04% 258
2017
Q1 		$768K Sell
23,928
-551
-2% -$18.8K 0.05% 220
2016
Q4 		$887K Buy
24,479
+5,104
+26% +$204K 0.06% 194
2016
Q3 		$891K Buy
19,375
+853
+5% +$44.5K 0.07% 193
2016
Q2 		$930K Sell
18,522
-373
-2% -$19.9K 0.07% 184
2016
Q1 		$1.01M Sell
18,895
-414
-2% -$24.3K 0.08% 176
2015
Q4 		$1.27M Buy
19,309
+114
+0.6% +$7.04K 0.1% 156
2015
Q3 		$1.08M Sell
19,195
-450
-2% -$29.2K 0.08% 183
2015
Q2 		$1.16M Buy
19,645
+404
+2% +$24.9K 0.08% 191
2015
Q1 		$1.2M Buy
19,241
+1,404
+8% +$81.6K 0.08% 184
2014
Q4 		$1.03M Sell
17,837
-973
-5% -$54.2K 0.07% 188
2014
Q3 		$1.01M Buy
18,810
+33
+0.2% +$1.75K 0.1% 153
2014
Q2 		$984K Sell
18,777
-214
-1% -$10.9K 0.09% 145
2014
Q1 		$1M Sell
18,991
-1,520
-7% -$70.3K 0.1% 143
2013
Q4 		$822K Sell
20,511
-8,599
-30% -$339K 0.09% 156
2013
Q3 		$1.1M Sell
29,110
-4,508
-13% -$176K 0.14% 121
2013
Q2 		$1.32M Buy
+33,618
New +$1.31M 0.17% 103

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

MAI Capital Management's TEVA Position: Q2 2026 in Review

MAI Capital Management increased its Teva Pharmaceuticals (TEVA) stake by 153% in Q2 2026, buying an estimated $179K and bringing the position to 8,901 shares worth $302K. The position accounts for ﹤0.01% of the portfolio, ranked #1585.

MAI Capital Management first reported a position in TEVA in Q2 2013 and has held it in 25 quarters since. The position peaked at $1.32M in Q2 2013. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • MAI Capital Management held 8,901 shares of Teva Pharmaceuticals worth $302K as of Q2 2026.
  • MAI Capital Management bought 5,377 Teva Pharmaceuticals shares in Q2 2026, an estimated $179K.
  • Teva Pharmaceuticals made up ﹤0.01% of MAI Capital Management's portfolio in Q2 2026, its #1585 holding.
  • MAI Capital Management first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 25 quarters since.
  • MAI Capital Management's Teva Pharmaceuticals position peaked at $1.32M in Q2 2013.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.